93 related articles for article (PubMed ID: 24736082)
1. A novel fusion of TPR and ALK in lung adenocarcinoma.
Choi YL; Lira ME; Hong M; Kim RN; Choi SJ; Song JY; Pandy K; Mann DL; Stahl JA; Peckham HE; Zheng Z; Han J; Mao M; Kim J
J Thorac Oncol; 2014 Apr; 9(4):563-6. PubMed ID: 24736082
[TBL] [Abstract][Full Text] [Related]
2. Oncogenic Function of a KIF5B-MET Fusion Variant in Non-Small Cell Lung Cancer.
Gow CH; Liu YN; Li HY; Hsieh MS; Chang SH; Luo SC; Tsai TH; Chen PL; Tsai MF; Shih JY
Neoplasia; 2018 Aug; 20(8):838-847. PubMed ID: 30015159
[TBL] [Abstract][Full Text] [Related]
3. Evolutionary Precision Medicine: A Role for Repeat Epidermal Growth Factor Receptor Analysis in ALK-Rearranged Lung Adenocarcinoma?
Birkbak NJ; Hiley CT; Swanton C
J Clin Oncol; 2015 Nov; 33(32):3681-3. PubMed ID: 26417000
[No Abstract] [Full Text] [Related]
4. Hepatoid carcinoma of the lung with anaplastic lymphoma kinase gene rearrangement.
Khozin S; Roth MJ; Rajan A; Smith K; Thomas A; Berman A; Giaccone G
J Thorac Oncol; 2012 Nov; 7(11):e29-31. PubMed ID: 23070248
[No Abstract] [Full Text] [Related]
5. [STRN::ALK fusion renal cell carcinoma with lung metastasis: report of a case].
Xian J; Yin XX; Wang DH; Zhang MX; Zheng LM; Zhou Q; Chen N
Zhonghua Bing Li Xue Za Zhi; 2024 Jun; 53(6):631-633. PubMed ID: 38825915
[TBL] [Abstract][Full Text] [Related]
6. ZC3HC1 Is a Novel Inherent Component of the Nuclear Basket, Resident in a State of Reciprocal Dependence with TPR.
Gunkel P; Iino H; Krull S; Cordes VC
Cells; 2021 Jul; 10(8):. PubMed ID: 34440706
[TBL] [Abstract][Full Text] [Related]
7. Mouse Model of Poorly Differentiated Thyroid Carcinoma Driven by STRN-ALK Fusion.
Nikitski AV; Rominski SL; Wankhede M; Kelly LM; Panebianco F; Barila G; Altschuler DL; Nikiforov YE
Am J Pathol; 2018 Nov; 188(11):2653-2661. PubMed ID: 30125543
[TBL] [Abstract][Full Text] [Related]
8. Coexistence of a novel intergenic (between CHST2 and SLC9A9)-ALK, TNIK-ALK double-fusion in resected lung adenocarcinoma.
Liu Z; Huang K; Wu Q; Zhou Q
Asian J Surg; 2024 Mar; 47(3):1505-1507. PubMed ID: 38071095
[No Abstract] [Full Text] [Related]
9. Letter to the Editor Regarding "Local ALK-Positive Histiocytosis with Unusual Morphology and Novel
Soylemez Akkurt T; Dur Karasayar AH; Gurbuz BC; Altınay S; Yuzkan S; Baskan F
Int J Surg Pathol; 2023 Oct; 31(7):1426-1429. PubMed ID: 36471533
[No Abstract] [Full Text] [Related]
10.
Mooradian MJ; Gainor JF
Oncologist; 2017 Jul; 22(7):759-761. PubMed ID: 28642334
[No Abstract] [Full Text] [Related]
11. STRN::ALK, a novel fusion to foetal lung interstitial tumour.
Paoli C; Di Mauro I; Coulomb A; Benadiba J; Lecompte JF; Dadone-Montaudié B; Burel-Vandenbos F
Histopathology; 2024 Jun; ():. PubMed ID: 38859770
[No Abstract] [Full Text] [Related]
12. SEC31A-ALK Fusion Gene in Lung Adenocarcinoma.
Kim RN; Choi YL; Lee MS; Lira ME; Mao M; Mann D; Stahl J; Licon A; Choi SJ; Van Vrancken M; Han J; Wlodarska I; Kim J
Cancer Res Treat; 2016 Jan; 48(1):398-402. PubMed ID: 25715771
[TBL] [Abstract][Full Text] [Related]
13. Two novel ALK mutations mediate acquired resistance to the next-generation ALK inhibitor alectinib.
Katayama R; Friboulet L; Koike S; Lockerman EL; Khan TM; Gainor JF; Iafrate AJ; Takeuchi K; Taiji M; Okuno Y; Fujita N; Engelman JA; Shaw AT
Clin Cancer Res; 2014 Nov; 20(22):5686-96. PubMed ID: 25228534
[TBL] [Abstract][Full Text] [Related]
14. Anchored multiplex PCR for targeted next-generation sequencing.
Zheng Z; Liebers M; Zhelyazkova B; Cao Y; Panditi D; Lynch KD; Chen J; Robinson HE; Shim HS; Chmielecki J; Pao W; Engelman JA; Iafrate AJ; Le LP
Nat Med; 2014 Dec; 20(12):1479-84. PubMed ID: 25384085
[TBL] [Abstract][Full Text] [Related]
15. The application of next-generation sequencing-based molecular diagnostics in endometrial stromal sarcoma.
Li X; Anand M; Haimes JD; Manoj N; Berlin AM; Kudlow BA; Nucci MR; Ng TL; Stewart CJ; Lee CH
Histopathology; 2016 Oct; 69(4):551-9. PubMed ID: 26990025
[TBL] [Abstract][Full Text] [Related]
16. Common Oncogene Mutations and Novel SND1-BRAF Transcript Fusion in Lung Adenocarcinoma from Never Smokers.
Jang JS; Lee A; Li J; Liyanage H; Yang Y; Guo L; Asmann YW; Li PW; Erickson-Johnson M; Sakai Y; Sun Z; Jeon HS; Hwang H; Bungum AO; Edell ES; Simon VA; Kopp KJ; Eckloff B; Oliveira AM; Wieben E; Aubry MC; Yi E; Wigle D; Diasio RB; Yang P; Jen J
Sci Rep; 2015 May; 5():9755. PubMed ID: 25985019
[TBL] [Abstract][Full Text] [Related]
17. Prospective genetic profiling of squamous cell lung cancer and adenosquamous carcinoma in Japanese patients by multitarget assays.
Kenmotsu H; Serizawa M; Koh Y; Isaka M; Takahashi T; Taira T; Ono A; Maniwa T; Takahashi S; Mori K; Endo M; Abe M; Hayashi I; Nakajima T; Ohde Y; Yamamoto N
BMC Cancer; 2014 Oct; 14():786. PubMed ID: 25348872
[TBL] [Abstract][Full Text] [Related]
18. Comprehensive analysis of RET and ROS1 rearrangement in lung adenocarcinoma.
Lee SE; Lee B; Hong M; Song JY; Jung K; Lira ME; Mao M; Han J; Kim J; Choi YL
Mod Pathol; 2015 Apr; 28(4):468-79. PubMed ID: 25234288
[TBL] [Abstract][Full Text] [Related]
19. Investigation of neurotrophic tyrosine kinase receptor 1 fusions and neurotrophic tyrosine kinase receptor family expression in non-small-cell lung cancer and sensitivity to AZD7451
Tatematsu T; Sasaki H; Shimizu S; Okuda K; Shitara M; Hikosaka Y; Moriyama S; Yano M; Brown J; Fujii Y
Mol Clin Oncol; 2014 Sep; 2(5):725-730. PubMed ID: 25054037
[TBL] [Abstract][Full Text] [Related]
20. Clinical Activity of Crizotinib in Lung Adenocarcinoma Harboring a Rare ZCCHC8-ROS1 Fusion.
Hicks JK; Boyle T; Albacker LA; Madison R; Frampton G; Creelan BC
J Thorac Oncol; 2018 Aug; 13(8):e148-e150. PubMed ID: 30049378
[No Abstract] [Full Text] [Related]
[Next] [New Search]
